Chronic stress helps tumors evade immune attack through gut microbes
Chronic psychological stress can help tumors evade immune attack through a chain of molecular events involving gut bacteria…
Duke researchers discover molecules that target vital cell signaling proteins
To function normally, nearly every cell in the human body relies on G-protein coupled receptors (GPCRs) to receive…
Early diabetes drug treatment links to better survival after diagnosis thresholds
New Korean health-screening data suggest prompt antidiabetic treatment after type 2 diabetes thresholds are crossed may improve survival,…
Study uncovers sex-specific immune pathway driving glioblastoma growth
Researchers have identified a critical biological difference in how glioblastoma develops in male and female laboratory models, pinpointing…
Scientists uncover new molecular mechanism driving gastrointestinal stromal tumors
Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the digestive tract, with KIT mutations driving…
Novel IL1RAP therapy advances toward pancreatic cancer clinical trial
Blocking IL1RAP, a receptor that sits at a key control point in inflammatory signaling, can disrupt the tumor-driven…
Engineered CAR-T cells offer potential rheumatoid arthritis cure
For the 18 million people living with rheumatoid arthritis, disease management currently means a lifetime of injections-a reality…
Heart failure treatments protect heart function during cancer therapy
The cardioprotective effects of heart failure treatments in patients with cancer were demonstrated today in a presentation at ESC…
Preoperative radiation boosts immunotherapy response in brain metastases
A new study led by researchers at The University of Texas MD Anderson Cancer Center demonstrated that pre-operative…
Study identifies immune pathway driving long-term concussion damage
Traumatic brain injuries (TBI) – even mild concussions – may trigger a chain reaction in the brain that…
GLP-1 medicines may cut clot-related risks in chronically inflamed patients
A large real-world analysis suggests GLP-1 receptor agonists may offer clot-related and survival benefits in a chronically inflamed,…
The next goal for weight loss drugs? Fewer injections
For millions of people taking weight loss drugs, the next breakthrough may not be more weight loss. It…